Related Experiment Video
Updated: Jun 19, 2026
08:05
An Efficient Method for Directed Hepatocyte-Like Cell Induction from Human Embryonic Stem Cells
Published on: May 6, 2021
In vitro model for the prediction of clinical CYP3A4 induction using HepaRG cells
A Kaneko1, M Kato, N Sekiguchi
1Pre-clinical Research Department, Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka, Japan. kanekoakh@chugai-pharm.co.jp
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|October 23, 2009
Summary
Predicting CYP3A enzyme induction is crucial for drug safety. This study developed a method using a relative factor (RF) to reduce assay variability and accurately predict clinical CYP3A induction, improving drug discovery.
Area of Science:
- Pharmacology and Toxicology
- Drug Metabolism and Pharmacokinetics
Background:
- CYP3A enzyme induction is critical to predict during drug discovery to prevent clinical adverse effects.
- In vitro assays for CYP3A induction exhibit significant variability, hindering reliable clinical predictions.
Purpose of the Study:
- To develop a method for correcting in vitro CYP3A induction assay variability.
- To establish a predictive model for CYP3A induction in a clinical setting.
Main Methods:
- In vitro induction assays were conducted using HepaRG cells and seven reference inducers.
- A relative factor (RF) was calculated as the ratio of inducer concentration to reference standards to normalize assay results.
- The relationship between the ratio of free steady-state plasma concentration (C(ss,u)) to RF (C(ss,u)/RF) and in vivo induction was analyzed.
Main Results:
- The relative factor (RF) effectively reduced variability among in vitro CYP3A induction assays.
- A strong correlation was observed between the C(ss,u)/RF ratio and the in vivo CYP3A induction response.
- Using rifampicin as a standard, compounds with a C(ss,u)/RF value > 7.31 nmol l(-1) were identified as potential in vivo human CYP3A inducers.
Conclusions:
- The developed method, utilizing the relative factor, improves the reliability of predicting clinical CYP3A induction from in vitro data.
- The C(ss,u)/RF ratio serves as a valuable predictive index for assessing the potential of drug candidates to induce CYP3A in humans.
